Bluejay Diagnostics Inc [BJDX] moved up 10.00: Why It’s Important

GFAI Stock

Bluejay Diagnostics Inc [NASDAQ: BJDX] traded at a high on Friday, posting a 10.00 gain after which it closed the day’ session at $0.55.

The results of the trading session contributed to over 47069303 shares changing hands. Over the past one week, the price volatility of Bluejay Diagnostics Inc stands at 20.11% while the volatility over the past one month is 14.95%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The market cap for BJDX stock reached $0.31 million, with 0.56 million shares outstanding and 0.48 million shares in the current float. Compared to the average trading volume of 426.34K shares, BJDX reached a trading volume of 47069303 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Bluejay Diagnostics Inc [BJDX]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BJDX shares is $256.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BJDX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Average True Range (ATR) for Bluejay Diagnostics Inc is set at 0.19 The Price to Book ratio for the last quarter was 0.05, with the Price to Cash per share for the same quarter was set at 4.75.

How has BJDX stock performed recently?

Bluejay Diagnostics Inc [BJDX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.42. With this latest performance, BJDX shares dropped by -12.70% in over the last four-week period, additionally sinking by -91.41% over the last 6 months – not to mention a drop of -98.80% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BJDX stock in for the last two-week period is set at 32.15, with the RSI for the last a single of trading hit 35.42, and the three-weeks RSI is set at 32.50 for Bluejay Diagnostics Inc [BJDX]. The present Moving Average for the last 50 days of trading for this stock 2.1049, while it was recorded at 0.5242 for the last single week of trading, and 10.3325 for the last 200 days.

Bluejay Diagnostics Inc [BJDX]: Deeper insight into the fundamentals

Bluejay Diagnostics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.26 and a Current Ratio set at 2.26.

Insider trade positions for Bluejay Diagnostics Inc [BJDX]

The top three institutional holders of BJDX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in BJDX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in BJDX stock with ownership which is approximately 5.1238%.

Most Popular